Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sensiia was a UK digital health and medical device company focused on fertility monitoring and conception support. The company, previously known as Cambridge Temperature Concepts, developed and commercialized DuoFertility, a wearable basal body temperature monitoring system paired with analytics and personalized fertility support to help users predict and confirm ovulation. Its offering combined a physiological sensing device with advisory services for couples trying to conceive, positioning the business in femtech, reproductive health, and connected health monitoring. The company appears to have generated revenue and raised venture and debt funding, but it later entered liquidation and is no longer active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sensiia.